×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.700
Biomarker
disease
CTD_human
Genomic landscape of cutaneous T cell lymphoma.
26192916
2015
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.700
Biomarker
disease
CTD_human
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
17634542
2007
×
Entrez Id:
51741
Gene Symbol:
WWOX
WWOX
0.610
Biomarker
disease
CTD_human
×
Entrez Id:
51741
Gene Symbol:
WWOX
WWOX
0.610
CausalMutation
disease
CGI
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.600
Biomarker
disease
CTD_human
Targeting the human EGFR family in esophagogastric cancer.
21468131
2011
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.600
Biomarker
disease
CTD_human
The EGFR CA repeat genetic polymorphism may act as a valuable molecular predictor of clinical outcome of esophageal cancer after CCRT and esophagectomy, especially in those with good response to CCRT.
21298351
2011
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.600
Biomarker
disease
CTD_human
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
22042947
2011
×
Entrez Id:
7048
Gene Symbol:
TGFBR2
TGFBR2
0.600
Biomarker
disease
CTD_human
A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
10789724
2000
×
Entrez Id:
7048
Gene Symbol:
TGFBR2
TGFBR2
0.600
CausalMutation
disease
CGI
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.600
CausalMutation
disease
CGI
×
Entrez Id:
125
Gene Symbol:
ADH1B
ADH1B
0.500
Biomarker
disease
CTD_human
Multiple ADH genes are associated with upper aerodigestive cancers.
18500343
2008
×
Entrez Id:
217
Gene Symbol:
ALDH2
ALDH2
0.500
Biomarker
disease
CTD_human
These results suggest that to help lower their risk for esophageal cancer , persons with the ALDH2 *2 allele should be encouraged to reduce their consumption of alcoholic beverages.
8850269
1996
×
Entrez Id:
6049
Gene Symbol:
RNF6
RNF6
0.500
Biomarker
disease
CTD_human
×
Entrez Id:
6049
Gene Symbol:
RNF6
RNF6
0.500
CausalMutation
disease
CGI
×
Entrez Id:
1630
Gene Symbol:
DCC
DCC
0.500
Biomarker
disease
CTD_human
×
Entrez Id:
1630
Gene Symbol:
DCC
DCC
0.500
CausalMutation
disease
CGI
×
Entrez Id:
11178
Gene Symbol:
LZTS1
LZTS1
0.500
Biomarker
disease
CTD_human
×
Entrez Id:
11178
Gene Symbol:
LZTS1
LZTS1
0.500
CausalMutation
disease
CGI
×
Entrez Id:
406991
Gene Symbol:
MIR21
MIR21
0.400
Biomarker
disease
CTD_human
Using 98 formalin-fixed, paraffin-embedded samples obtained from patients with esophageal cancer who had received preoperative chemotherapy followed by surgery, we measured expression levels of several miRNAs that are considered to be involved in the regulation of stem cell function (e.g., let-7a, let-7g, miR-21 , miR-134, miR-145, miR-155, miR-200c, miR-203, and miR-296) by real-time reverse transcriptase PCR.
21248297
2011
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
0.400
Biomarker
disease
CTD_human
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.
21472143
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
0.400
Biomarker
disease
CTD_human
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
22042947
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.400
Biomarker
disease
CTD_human
Progressive silencing of p14ARF in oesophageal adenocarcinoma.
18410530
2009
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
0.400
Biomarker
disease
CTD_human
We evaluated the effects of specific COX-2 inhibitors, NS-398 and nimesulide, on cell lines of both histological types of OC .
17707579
2007
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
0.400
Biomarker
disease
CTD_human
We analyzed the association of COX-2 mRNA and protein expression with histomorphologic response to neoadjuvant radiochemotherapy in esophageal cancer .
16322294
2005
×
Entrez Id:
595
Gene Symbol:
CCND1
CCND1
0.400
Biomarker
disease
CTD_human
Whereas L2D1(+) mice exhibit a histologic phenotype of oral-esophageal dysplasia, the combination of cyclin D1 expression and p53 deficiency results in invasive oral-esophageal cancer .
12235107
2002